HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of Soluble Extracellular Regions of MmpL (SERoM) as Vaccines for Tuberculosis.

Abstract
The current vaccine for tuberculosis (TB) is a live attenuated strain of Mycobacterium bovis (BCG) and while effective at reducing the potential for disseminated TB in young children its disease protection rates in adults is highly variable while it confers little protection against latent TB. With these limitations a new vaccine is desperately needed. We investigated the efficacy of three members of the mycobacterial membrane protein Large (MmpL) family as potential subunit vaccines for TB. MmpLs are large, multifunctional integral membrane proteins, and as such are recalcitrant to purification. Here, we describe a strategy of producing synthetic antigens comprised of the soluble, extracellular regions of MmpL (SERoM)-1, MmpL8 and MmpL10 (SERoM-8 and 10 respectively) as potential vaccine candidates. SERoM-1 and SERoM-8 were determined to be highly immunogenic by IFN-γ ELISpot assays, with 0.1% of all splenocytes from SERoM-1 vaccinated mice producing IFN-γ when re-stimulated with MmpL1. A combined SERoM-1, -8 and -10 vaccine demonstrated significant protection against M. tuberculosis challenge in a murine model of TB, resulting in approximately 10-fold reduction in bacterial numbers following challenge in both the lungs and spleens compared to adjuvant only vaccinated mice. These protective effects were comparable to that achieved with BCG.
AuthorsEmily J Strong, Nicholas P West
JournalScientific reports (Sci Rep) Vol. 8 Issue 1 Pg. 5604 (04 04 2018) ISSN: 2045-2322 [Electronic] England
PMID29618733 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bacterial Proteins
  • Membrane Transport Proteins
  • MmpL3 protein, Mycobacterium tuberculosis
  • Recombinant Proteins
  • Tuberculosis Vaccines
  • Vaccines, Synthetic
  • Interferon-gamma
Topics
  • Animals
  • Bacterial Proteins (chemistry, genetics, metabolism)
  • Escherichia coli (metabolism)
  • Interferon-gamma (metabolism)
  • Lung (microbiology, pathology)
  • Membrane Transport Proteins (chemistry, genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mycobacterium tuberculosis (metabolism)
  • Recombinant Proteins (biosynthesis, immunology, isolation & purification)
  • Spleen (cytology, metabolism)
  • Tuberculosis (immunology, pathology, prevention & control)
  • Tuberculosis Vaccines (immunology)
  • Vaccines, Synthetic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: